AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:AMN • US0017441017

19.93 USD
-0.37 (-1.82%)
At close: Feb 9, 2026
19.93 USD
0 (0%)
After Hours: 2/9/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, AMN scores 4 out of 10 in our fundamental rating. AMN was compared to 102 industry peers in the Health Care Providers & Services industry. AMN has an average financial health and profitability rating. AMN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • AMN had positive earnings in the past year.
  • AMN had a positive operating cash flow in the past year.
  • Of the past 5 years AMN 4 years were profitable.
  • AMN had a positive operating cash flow in each of the past 5 years.
AMN Yearly Net Income VS EBIT VS OCF VS FCFAMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • AMN has a worse Return On Assets (-12.88%) than 75.49% of its industry peers.
  • AMN has a Return On Equity of -42.76%. This is in the lower half of the industry: AMN underperforms 71.57% of its industry peers.
  • The Return On Invested Capital of AMN (2.08%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for AMN is above the industry average of 9.11%.
  • The 3 year average ROIC (13.14%) for AMN is well above the current ROIC(2.08%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -12.88%
ROE -42.76%
ROIC 2.08%
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
AMN Yearly ROA, ROE, ROICAMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • With a Operating Margin value of 1.65%, AMN perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
  • AMN's Operating Margin has declined in the last couple of years.
  • AMN's Gross Margin of 29.37% is in line compared to the rest of the industry. AMN outperforms 58.82% of its industry peers.
  • AMN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.65%
PM (TTM) N/A
GM 29.37%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
AMN Yearly Profit, Operating, Gross MarginsAMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMN is still creating some value.
  • AMN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for AMN has been reduced compared to 5 years ago.
  • AMN has a better debt/assets ratio than last year.
AMN Yearly Shares OutstandingAMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AMN Yearly Total Debt VS Total AssetsAMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • AMN has an Altman-Z score of 2.46. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • AMN has a Altman-Z score (2.46) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of AMN is 3.80, which is a good value as it means it would take AMN, 3.80 years of fcf income to pay off all of its debts.
  • AMN's Debt to FCF ratio of 3.80 is fine compared to the rest of the industry. AMN outperforms 72.55% of its industry peers.
  • AMN has a Debt/Equity ratio of 1.31. This is a high value indicating a heavy dependency on external financing.
  • AMN has a worse Debt to Equity ratio (1.31) than 65.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.8
Altman-Z 2.46
ROIC/WACC0.26
WACC7.88%
AMN Yearly LT Debt VS Equity VS FCFAMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • AMN has a Current Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
  • AMN has a Current ratio of 1.05. This is in the lower half of the industry: AMN underperforms 67.65% of its industry peers.
  • AMN has a Quick Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of AMN (1.05) is worse than 61.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
AMN Yearly Current Assets VS Current LiabilitesAMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for AMN have decreased strongly by -51.29% in the last year.
  • The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
  • The Revenue for AMN has decreased by -11.42% in the past year. This is quite bad
  • AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.07% yearly.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%

3.2 Future

  • The Earnings Per Share is expected to grow by 22.82% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y-57.04%
EPS Next 2Y-54.6%
EPS Next 3Y-30.54%
EPS Next 5Y22.82%
Revenue Next Year-8.07%
Revenue Next 2Y-6.86%
Revenue Next 3Y-3.35%
Revenue Next 5Y4.4%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMN Yearly Revenue VS EstimatesAMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
AMN Yearly EPS VS EstimatesAMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.54, which indicates a very decent valuation of AMN.
  • 90.20% of the companies in the same industry are more expensive than AMN, based on the Price/Earnings ratio.
  • AMN is valuated cheaply when we compare the Price/Earnings ratio to 28.06, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 29.21, which means the current valuation is very expensive for AMN.
  • The rest of the industry has a similar Price/Forward Earnings ratio as AMN.
  • AMN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.54
Fwd PE 29.21
AMN Price Earnings VS Forward Price EarningsAMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 80.39% of the companies listed in the same industry.
  • AMN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMN is cheaper than 98.04% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.44
EV/EBITDA 7.65
AMN Per share dataAMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • A cheap valuation may be justified as AMN's earnings are expected to decrease with -30.54% in the coming years.
PEG (NY)N/A
PEG (5Y)13.11
EPS Next 2Y-54.6%
EPS Next 3Y-30.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for AMN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMN HEALTHCARE SERVICES INC

NYSE:AMN (2/9/2026, 8:04:00 PM)

After market: 19.93 0 (0%)

19.93

-0.37 (-1.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)02-19
Inst Owners109.44%
Inst Owner Change-3.94%
Ins Owners0.45%
Ins Owner Change9.04%
Market Cap765.51M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target21.27 (6.72%)
Short Float %6.27%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)2.1%
PT rev (3m)1.39%
EPS NQ rev (1m)2.3%
EPS NQ rev (3m)24.26%
EPS NY rev (1m)2.26%
EPS NY rev (3m)23.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.59%
Valuation
Industry RankSector Rank
PE 10.54
Fwd PE 29.21
P/S 0.28
P/FCF 3.44
P/OCF 2.87
P/B 1.19
P/tB N/A
EV/EBITDA 7.65
EPS(TTM)1.89
EY9.48%
EPS(NY)0.68
Fwd EY3.42%
FCF(TTM)5.8
FCFY29.1%
OCF(TTM)6.94
OCFY34.84%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)13.11
Graham Number26.71
Profitability
Industry RankSector Rank
ROA -12.88%
ROE -42.76%
ROCE 2.81%
ROIC 2.08%
ROICexc 2.16%
ROICexgc 6.84%
OM 1.65%
PM (TTM) N/A
GM 29.37%
FCFM 8.2%
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.8
Debt/EBITDA 4.12
Cap/Depr 27.3%
Cap/Sales 1.62%
Interest Coverage 0.95
Cash Conversion 129.62%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 2.46
F-Score4
WACC7.88%
ROIC/WACC0.26
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-57.04%
EPS Next 2Y-54.6%
EPS Next 3Y-30.54%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-8.07%
Revenue Next 2Y-6.86%
Revenue Next 3Y-3.35%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year103.44%
EBIT Next 3Y20.38%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%

AMN HEALTHCARE SERVICES INC / AMN FAQ

What is the fundamental rating for AMN stock?

ChartMill assigns a fundamental rating of 4 / 10 to AMN.


Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?

ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.


How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?

AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.


What is the earnings growth outlook for AMN HEALTHCARE SERVICES INC?

The Earnings per Share (EPS) of AMN HEALTHCARE SERVICES INC (AMN) is expected to decline by -57.04% in the next year.